Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluBlok vs TIV in Adults 50-64
NCT00539864Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Sep 2007; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00539864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539864.